49
Participants
Start Date
April 30, 2009
Primary Completion Date
November 30, 2009
Study Completion Date
November 30, 2009
Ultrase® MT12
Ultrase® MT12 capsules will be given orally daily based on investigator's discretion to a maximum dose of 2,500 lipase units per kilogram (kg) body weight per meal or snack for 19 to 24 days during the treatment phase. Total maximum dose not to exceed 10,000 lipase units/kg/day.
SUNY Upstate Medical University, Syracuse
Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Pennsylvania State University and the Milton S. Hershey Medical Center, Hershey
Virginia Commonwealth University, Richmond
Duke University Medical Center, Durham
Helen DeVos Children's Hospital-Spectrum Health Research Department, Grand Rapids
Rainbow Babies and Children's Hospital - Cystic Fibrosis Center, Cleveland
Children's Medical Center of Dayton, Dayton
UW Hospital and Clinics, Madison
University of Oklahoma Health Sciences Center, Oklahoma City
Respiratory Diseases of Children and Adolescents, Oklahoma City
The Children's Hospital, Aurora
University of Utah, Salt Lake City
University of Michigan Health System Cystic Fibrosis Center, Ann Arbor
Sanford Children's Specialty Clinic, Sioux Falls
Lead Sponsor
Forest Laboratories
INDUSTRY